Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.965 EUR | +1.58% | +1.05% | +1.05% |
06-23 | Hamilton Thorne Maintained at Buy at Stifel GMP on No Impact From U.S. IVF Actions; Price Target Kept at C$2.55 | MT |
05-14 | Hamilton Thorne Q1 Loss Widens Even as Sales Increase | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company sustains low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 86.38 times its estimated earnings per share for the ongoing year.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.05% | 162M | - | ||
+8.00% | 185B | B- | ||
+31.86% | 158B | B- | ||
+33.21% | 113B | A- | ||
+2.28% | 64.32B | A- | ||
+21.14% | 55.66B | B+ | ||
+0.11% | 48.41B | B+ | ||
-6.76% | 37.82B | A | ||
+0.78% | 35.57B | - | ||
+11.28% | 28.12B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HTL Stock
- 0ZM Stock
- Ratings Hamilton Thorne Ltd.